FDA Issues Final Guidance on Therapeutic Equivalence
Today, the FDA issued the final guidance titled Evaluation of Therapeutic Equivalence (here). The guidance is essentially identical to one with the same title issued in July 2022. There are only a few changes from the draft guidance, which include revisions to reflect an additional process by which applicants of certain 505(b)(2) applications may request […]
